middle.news
Cynata stretches toward FY2028 runway after sweeping cost cuts
9:50am on Tuesday 27th of October, 2026 AEDT
•
Biotechnology
Read Story
Cynata stretches toward FY2028 runway after sweeping cost cuts
9:50am on Tuesday 27th of October, 2026 AEDT
Key Points
A$175,000 cash at 30 September after A$1.316 million quarterly operating outflows
All employee positions made redundant and outsourced trial work suspended or terminated
A$1.694 million R&D tax refund received after quarter end, with A$1.067 million left after loan repayment
Fully underwritten A$913,000 entitlement offer supports the proposed runway extension
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Cynata Therapeutics (ASX:CYP)
OPEN ARTICLE